Weslaco Chamber and South Texas Health System to host Lunch and Learn Seminar Thursday, May 10

Community News
496

Translate to Spanish or other 102 languages!

Dr. Oscar Cano will present on breast cancer awareness and screening at the next Weslaco Chamber Lunch and Learn Seminar on Thursday, May 10 at 12 pm at the Business Visitor & Event Center in Weslaco.
Dr. Oscar Cano will present on breast cancer awareness and screening at the next Weslaco Chamber Lunch and Learn Seminar on Thursday, May 10 at 12 pm at the Business Visitor & Event Center in Weslaco.

Mega Doctor News

- Advertisement -

The Weslaco Chamber of Commerce will host a Lunch and Learn Seminar on Thursday, May 10 at 12 pm at the Business Visitor Center in Weslaco. The seminar, sponsored by South Texas Health System, will cover breast cancer awareness and mammography screening.

Presenter Dr. Oscar Cano is the Lead Interpreting Physician for Breast Imaging for STHS. Celebrate Día de las Madres with a fiesta themed lunch! Admission fee is $5 for attendees. Call 968-2102 to RSVP. The Weslaco Business Visitor and Event Center is located at 275 S. Kansas.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Mega Doctor: “Our Health is the Most Important Thing We Have in Life” – Dr. Eduardo Candanosa
Next article
Publisher’s Word: Even If It Is Hard, You Have to Take Care of Your Health

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -